In this article, we present a clinical description of Alzheimer's disease, review extant literature regarding the prevalence of dementia of the Alzheimer's type in people with Down syndrome, and discuss the relationship between Alzheimer's-type neuropathology and Alzheimer's type dementia in people
Changes in erythrocyte ouabain binding with age in down's syndrome and in controls
β Scribed by Dr G. J. Naylor; B. Shepherd; D. Findlay; S. Young; D. McRae
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 270 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0885-6230
No coin nor oath required. For personal study only.
β¦ Synopsis
Ouabain binding was estimated in erythrocytes from 31 patients with trisomy 21 and 32 matched mentally handicapped controls. The ouabain binding of the control group decreased significantly with age, as expected, but this change did not occur in the Down's syndrome group. However, the ouabain binding of the younger (less than 40 years) Down's group was significantly lower than that of the younger controls and simply remained low in the older group.
π SIMILAR VOLUMES
## Abstract ## Objectives To determine the prevalence of dementia in an Irish sample of people with Down's syndrome (DS) and to examine associated clinical characteristics of dementia in this group. ## Method 285 people with DS (Age 35β74 years, mean ageβΒ±βSD 46.5βΒ±β8.2 years) were included in t
Some indirect relationships between contraception failures and offspring with a pathological condition are reviewed, and a causal connection between them is suggested. This hypothesis is supported by the decreasing incidence of Down syndrome (DS) in general in recent years, and the increase among th
**Background** A population sample with Down's syndrome has been studied repeatedly since infancy, and has now been followed up again at age 35βyears. **Methods** Intelligence, language, reading and arithmetic were tested and daily living skills were assessed. Two memory tests, the Rivermead Behavi
Women with Down's syndrome experience early onset of both menopause and Alzheimer's disease. This timing provides an opportunity to examine the influence of endogenous estrogen deficiency, indicated by age at menopause, on risk of Alzheimer's disease. A community-based sample of 163 postmenopausal w